Drugmaker Bristol-Myers Squibb has agreed to settle claims that it improperly marketed its antipsychotic drug Abilify by paying out $19.5 million to 42 states.
- Judge Tosses Hazing Claims Against Penn State, Fraternity
- Post Subsidiary Agrees to Pay $75M in Eggs Antitrust Case
- Touting Public Service, Fattah Seeks Lighter Sentence
- Former Rep. Cohen Joins Rovner Firm, Plans Judicial Run
- Invokana Kidney Damage MDL Established in New Jersey
- Fast-food CEO and Regulation Foe Andrew Puzder Is Trump Pick for DOL Chief
Pennsylvania attorneys are giving a collective sigh of relief in the wake of the state Supreme Court's decision last week to block efforts aimed at reinstating a nearly $1 million sanction against a Philadelphia-area defense attorney.
A contingency fee agreement including a financial penalty for termination of the attorney-client relationship would chill a client's right to seek counsel of their choice, the state Supreme Court was told Tuesday at oral argument by a lawyer who urged the justices to bar enforcement of the provision.
Read about surveillance evidence, manufacturer responsibility in autonomous vehicle cases and piercing limited tort with a 'soft tissue' injury in The Legal's Personal Injury supplement.
In the Legal’s Top Women in Law supplement learn more about our 2016 honorees and read articles about new generations of female attorneys, mentoring and career advancement.